eISSN: 2299-551X
ISSN: 0011-4553
Journal of Stomatology
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
vol. 72
Original paper

Association between blood groups and odontogenic lesions: a preliminary report

Rasoul Gheisari
Tayebeh Doroodizadeh
Firoozeh Estakhri
Azadeh Andisheh Tadbir
Reza Sayyad Soufdoost
Seyed Ali Mosaddad

J Stoma 2019; 72, 6: 269-273
Online publish date: 2020/03/22
Article file
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero


There are some pathological problems related to oral tissues. Cysts and tumors of the jaw are common clinical and pathological findings, and are classified as odontogenic or non-odontogenic on the basis of their origins. Studies on these cysts and tumors are highly valuable given their aggressive behavioral pattern and difficult diagnosis [1-5]. Odontogenic keratocysts (OKCs) results from a proliferation of epithelial dental lamina in both jaws. OKCs are mostly benign lesions with aggressive behavior and present a typical alveolar bulge as they expand along the jaw. Although these lesions can expand the jaw, they are usually asymptomatic and are discovered through an incidental radiographic image, as they mainly expand in the anteroposterior dimension [14]. Radicular cysts have an inflammatory origin and develop either from the epithelial remnants in the periodontal space or from a necrosed pulp. These lesions cannot be easily identified given their small size, and are frequently discovered as an incidental finding through routine radiographic examinations [6, 7]. Ameloblastomas are tumors with an odontogenic source that originates from epithelial deposits of the tooth germ, stratified squamous epithelium of odontogenic cysts, and epithelium of enamel organ. Ameloblastomas are a clinically aggressive odontogenic tumor (ameloblastomas without histopathological features of malignancy are clinically considered as locally malignant), that grow slowly without any expansion, therefore, remain an asymptomatic most of the time [8, 9]. Dentigerous cysts originate through the separation of the follicle from the crown of an unerupted tooth. They are generally associated with the crowns of impacted or unerupted permanent teeth, but they may also be associated with an odontoma, developing teeth, and even deciduous teeth [10]. Patients with dentigerous cysts are mostly asymptomatic in early stages and exhibit no painful symptoms unless in presence of an acute inflammatory exacerbation; thus, these lesions are often detected incidentally during routine radiographic examination [11]. The diverse characteristics of these lesions complicate the prediction of a specific pattern for the pathogenesis of maxillofacial lesions. Nevertheless, epidemiological evaluations can reveal relationships between some lesions or accompanying diseases and some genetic characteristics of the patient. These associations will help to guide the identification and treatment of lesions. The ABO blood group system was established by the Austrian scientist Karl Landsteiner at the University of Vienna in 1901. The ABO locus is present on chromosome 9q34, and the ABO gene is autosomal. Different blood groups have various distributions among countries and ethnicities. Among all blood types, the O blood type is the most prevalent blood type, whereas the AB blood type is the least predominant [12-14].
Certain blood types are associated with some diseases, including hepatitis B [15], vascular diseases, abdominal aortic aneurism, gastric and duodenal ulcer, and cancers [16].


In the present study, we evaluated the relationship between ABO blood groups and odontogenic lesions in patients to address the lack of coherent and adequate researches on this topic.


This study was approved by the Shiraz University of Medical Sciences. A simple random sampling was performed in this retrospective study. Specifically, 129 cases that were histopathologically diagnosed with radicular cysts, odontogenic keratocyst, dentigerous cysts, and ameloblastomas over the period of 2005 to 2016 with complete data were enrolled. The medical files of all patients were analyzed with regard to gender, blood type, and odontogenic lesion type. Data were analyzed using SPSS 18 (Statistical Package for the Social Sciences, version 23.0, SPSS Inc. Chicago, IL, USA) and χ2 test. P value < 0.05 was considered as significant.


A total number of 129 patients with odontogenic lesions and known blood groups were recorded over the period of 2005 to 2016. Among 129 cases, 76 (58.9%) patients were male and 53 (41.1%) patients were female. The most common blood type was O, with 51 (39.5%) subjects, followed by A with 38 (29.4%) patients, B with 22 (17.1%) cases, and AB with 18 (14%) patients. The number of subjects per blood type is shown in Table 1.
Among these cases, 47 (36.4%), 39 (30.2%), 22 (17.1%), and 21 (16.3) had a dentigerous cyst, odontogenic keratocyst, radicular cyst, or ameloblastoma, respectively. The number of cases of odontogenic lesions by type are summarized in Table 2.
The distribution of blood groups among these 129 patients by odontogenic lesion type is shown in Table 3.
Blood types B and AB were associated with high incidence of odontogenic lesions, whereas blood groups O and A were associated with low incidence of odontogenic lesions (p < 0.05).
Blood types and radicular cyst, ameloblastoma, and odontogenic cyst incidences were not associated (p > 0.05). However, blood types B and AB were associated with high incidence of dentigerous cysts (p < 0.05).
The present study also showed that the odontogenic lesions evaluated were more prevalent in men (n = 76, 59%) than in women (n = 53, 41%). Also, the number of patients with dentigerous cysts was higher than the number of those with the other examined odontogenic lesions, followed by OKCs, radicular cysts, and ameloblastoma tumors, whereas in previous studies, the most common odontogenic lesions were radicular cysts, followed by dentigerous cysts, OKCs, and ameloblastoma tumors, which is a noticeable finding. According to the results, odontogenic lesions were more prevalent in blood type O, followed by blood types A and B. The lowest incidence of these lesions was in blood type AB. Based on these findings and their comparison with the frequency distribution of blood types in Iranians and the global population, the frequency distribution of odontogenic lesions in the studied patients by blood type was consistent with the frequency distribution of blood types in Iranians and the global population. The comparison of the data in Table 4 and the statistical analysis performed by the c2 test showed a significant difference between the frequency distribution of blood types A and AB in the studied population with its normal distribution in the general population (p < 0.001). In other words, people with blood types B and AB were at a higher risk of developing odontogenic lesions than those with other blood types, which was similar to an earlier study by the same researchers that found a relationship between blood type and maxillofacial deformities. Also, the lowest risk of these lesions was observed in blood type A.
Comparing the total number of patients with each blood type (A, B, AB, and O) among the 129 patients with the four common odontogenic lesions under study and the expected number of patients in each blood type based on the normal distribution of blood types in Iran revealed a p-value less than 0.001. In other words, there was a significant relationship between blood type and the rate of development of odontogenic lesions. Based on the statistical analyses performed, patients with odontogenic lesions and blood types B and AB have risk factors for odontogenic lesions.
In the patients with OKC, the number of cases with blood types A and O was lower than the expected number based on the normal percentage of people with these blood types in the general population, and the number of patients with blood types B and AB was higher than expected (Table 5).
In the patients with radicular cysts, the number of patients with blood types A and B was lower than expected, and the number of patients with blood types AB and O was higher than expected (Table 6).
In patients with ameloblastoma tumors, the number of patients with blood types AB and O was lower than expected, and the number of patients with blood types A and B was higher than expected (Table 7).
In the patients with OKC, radicular cysts, and ameloblastoma tumors, p-value was more than 0.05, which revealed non-significance of relationship between these lesions and blood type, and could be due to small sample size. In the patients with dentigerous cysts, the number of patients with blood types A and O was lower than expected and the number of patients with blood types B and AB was higher than expected. In the dentigerous cyst cases, p-value was less than 0.05, which indicated that there was a significant relationship between blood type and development of dentigerous cysts. Based on the findings, people with blood types B and AB had a higher risk of developing dentigerous cysts, which was consistent with the present findings regarding the general comparison of relationship between the development of odontogenic lesions and blood type. The present findings were also consistent with the results of previous studies on the relationship between maxillofacial deformities and blood type (Table 8).


Antigens of the AB0 blood group are essential antigens in transfusion medicine [15-17], but their association with certain diseases remains unclear. The relationship between blood types and disease incidence was first hypothesized in the mid-1900s [18]. In 2008, Gheisari et al. [19] reported that ABO blood types and maxillofacial deformities are linked. Their results suggest an existing relationship between ABO blood types and certain diseases, which are consistent with our findings showing this relationship between blood types and odontogenic lesions. They also showed that among all blood types, blood type B has the highest association with maxillofacial deformities and blood type A has the lowest, which was found in our study regarding odontogenic lesions. Sidhu et al. investigated the association between ABO blood types and diabetes mellitus. They found that diabetes mellitus is associated with blood type AB [20]. Meo et al. Reported that subjects with blood type B are at high risk of diabetes mellitus type 2, whereas individuals with blood type O are at low-risk of this disease [18]. The results of these above mentioned studies suggest that diabetes was more prevalent in blood types AB and B considering our results. Therefore, we can state more strongly that there is a relationship between these two blood types and certain conditions. Hsiao et al. suggested that ABO blood types are significantly associated with cancer risk. Men with AB blood type, women with A blood type, and subjects with A antigen were more likely to develop cancers than other subjects [14]. Bijanzadeh et al. stated that ABO blood types have a non-significant association with asthma among Indian population [21]. These results reveal that ABO blood types may have a relationship with certain conditions, which require more investigations to find out. Mortazavi et al. observed that individuals with blood type B are at a higher risk of developing oral cancer than individuals with other blood types [22]. Xie et al. demonstrated that the risk of developing skin squamous cell carcinoma is significantly lower in patients with blood type A than in patients with other blood types [23]. As our results demonstrated, blood type A had the least relationship to odontogenic lesions. Jin et al. showed that ABO blood types are associated with survival in patients with laryngeal cancer. Patients with blood type O have significantly shorter overall survival than patients with other blood types [24]. These results are consistent with our study, which found that blood types B and AB are associated with higher incidences of odontogenic lesions.


The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.


1. Khojaste M, Yazdanian M, Tahmasebi E, Shokri M, Houshmand B, Shahbazi R. Cell toxicity and inhibitory effects of Cyperus rotundus extract on Streptococcus mutans, Aggregatibacter actinomycetemcomitans and Candida albicans. Eur J Transl Myol 2018; 28: 7917.
2. Khomarlou N, Aberoomand-Azar P, Lashgari AP, et al. Essential oil composition and in vitro antibacterial activity of Chenopo¬dium album subsp. striatum. Acta Biologica Hungarica 2018; 69: 144-155.
3. Mosaddad SA, Tahmasebi E, Yazdanian A, et al. Oral microbial biofilms: an update. Eur J Clin Microbiol Infect Dis 2019; 38: 2005-2019.
4. Pazdera J, Kolar Z, Zboril V, Tvrdy P, Pink R. Odontogenic keratocysts/keratocystic odontogenic tumours: biological characteristics, clinical manifestation and treatment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014; 158: 170-174.
5. Soufdoost RS, Yazdanian M, Tahmasebi E, et al. In vitro and in vivo evaluation of novel Tadalafil/β-TCP/Collagen scaffold for bone regeneration: a rabbit critical-size calvarial defect study. Biocybernetics and Biomedical Engineering 2019; 39: 789-796.
6. Joshi NS, Sujan SG, Rachappa MM. An unusual case report of bilateral mandibular radicular cysts. Contemporary Clinical Dentistry 2011; 2: 59-62.
7. Kafshgari HS, Yazdanian M, Ranjbar R, et al. The effect of Citrullus colocynthis extracts on Streptococcus mutans, Candida albicans, normal gingival fibroblast and breast cancer cells. J Biol Res 2019; 92: 3.
8. Masthan KM, Anitha N, Krupaa J, Manikkam S. Ameloblastoma. J Pharm Bioallied Sci 2015; 7: S167-170.
9. Karami A, Tebyanian H, Goodarzi V, Shiri S. Planarians: an in vivo model for regenerative medicine. Int J Stem Cells 2015; 8: 128-133.
10. Johnson NR, Gannon OM, Savage NW, Batstone MD. Frequency of odontogenic cysts and tumors: a systematic review. J Investig Clin Dent 2014; 5: 9-14.
11. Daley TD, Wysocki GP. The small dentigerous cyst. A diagnostic dilemma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 77-81.
12. Babavalian H, Latifi AM, Shokrgozar MA, Bonakdar S, Tebyanian H, Shakeri F. Cloning and expression of recombinant human platelet-derived growth factor-BB in Pichia Pink. Cell Mol Biol (Noisy-le-grand) 2016; 62: 45-51.
13. Heidari MF, Arab SS, Noroozi-Aghideh A, Tebyanian H, Latifi AM. Evaluation of the substitutions in 212, 342 and 215 amino acid positions in binding site of organophosphorus acid anhydrolase using the molecular docking and laboratory analysis. Bratisl Lek Listy 2019; 120: 139-143.
14. Hsiao LT, Liu NJ, You SL, Hwang LC. ABO blood group and the risk of cancer among middle-aged people in Taiwan. Asia Pac J Clin Oncol 2015; 11: e31-36.
15. Siransy LK, Nanga ZY, Zaba FS, Tufa NY, Dasse SR. ABO/Rh Blood Groups and Risk of HIV Infection and Hepatitis B Among Blood Donors of Abidjan, Cote D’ivoire. Eur J Microbiol Immunol (Bp) 2015; 5: 205-209.
16. Anstee DJ. The relationship between blood groups and disease. Blood 2010; 115: 4635-4643.
17. Taherian A, Fazilati M, Moghadam AT, Tebyanian H. Optimization of purification procedure for horse F(ab´)2 antivenom against Androctonus crassicauda (Scorpion) venom. Trop J Pharm Res 2018; 17: 409-414.
18. Meo SA, Rouq FA, Suraya F, Zaidi SZ. Association of ABO and Rh blood groups with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci 2016; 20: 237-242.
19. Gheisari R, Ghoreishian M, Movahedian B, Roozbehi A. The association between blood groups and maxillofacial deformities. Indian J Plast Surg 2008; 41: 138-140.
20. Sidhu LS, Malhotra P, Singh SP. ABO and Rh blood groups in diabetes mellitus. Anthropol Anz 1988; 46: 269-275.
21. Bijanzadeh M, Ramachandra NB, Mahesh PA, Savitha MR, Manjunath BS, Jayaraj BS. Lack of association between asthma and ABO blood group. Lung 2009; 187: 389-392.
22. Mortazavi H, Hajian S, Fadavi E, Sabour S, Baharvand M, Bakhtiari S. ABO blood groups in oral cancer: a first case-control study in a defined group of Iranian patients. Asian Pac J Cancer Prev 2014; 15: 1415-1418.
23. Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PLoS One 2010; 5: e11972.
24. Jin T, Li PJ, Chen XZ, Hu WH. ABO blood group is a predictor of survival in patients with laryngeal cancer. Chin J Cancer 2016; 35: 90.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe